Innovation

New Therapeutic Leads for Cachexia and Anorexia: Design of a Small Protein that Significantly Enhances Mammalian Feeding

University of California System: University of California, Santa Cruz
posted on 10/20/2011

 The agouti-related protein (AgRP) is produced in the brain and is a potent appetite stimulant. The normal 50 amino acid polypeptide is produced in the hypothalamus and binds with high affinity to the melanocortin 3 and 4 receptors (MC3R and MC4R). Along with alpha-melanocyte stimulating hormone (apha-MSH) and neuropeptide Y, AgRP plays a central role in the regulation of mammalian feeding and metabolism. From intracerebroventricular (ICV) injection studies, AgRP is well documented to enhance feeding for one to two days following a single injection, and is probably longer acting than any other known hormone or drug. 

Suggested Uses

UCSC researchers believe that these proteins will ultimately be of value in treating extreme cases of eating disorders such as anorexia or cachexia. Furthermore, the principles used in the design of these proteins may find value in the development of therapeutics.

Advantages

The animals increase their body weight by 15% in a one week period, compared to 5% in animals treated with wild type AgRP.


Innovation Details
 

Detailed Description

UCSC researchers have previously isolated the specific region of AgRP that is required to bind to the MC receptors. New studies show regions adjacent to those that make receptor contact are rich with positive charges, and while they do not influence receptor affinity, they’re critical for AgRP’s long acting activity. UCSC researchers have now designed non-natural proteins where they’ve selectively enhanced certain sequence and charge characteristics and are able to greatly extend the time over which a single AgRP injection stimulates feeding. Normally, from ICV injections in rats, AgRP stimulates feeding over a 24 – 72 hour period, one to three days. UCSC researchers show that the newly designed protein stimulates feeding for six days. Moreover, the cumulative food intake stimulated by UCSC’s designed AgRP is approximately double that of control over the lifetime of the experiment. The animals increase their body weight by 15% in a one week period, compared to 5% in animals treated with wild type AgRP.

File Number: 22013 

Disease: Women's Health


IP Protection

Copyright: ©2011-2012, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact University of California, Santa Cruz Office for Management of Intellectual Property at University of California System: University of California, Santa Cruz for more information.

Request more info via email request more info
People

Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...